4D Molecular Therapeutics Inc

NASDAQ:FDMT   3:59:54 PM EDT
32.68
-0.26 (-0.79%)
Products

4D Molecular Therapeutics Inc Announces FDA Clearance Of IND Application For 4D-710

Published: 10/06/2021 11:44 GMT
4D Molecular Therapeutics Inc (FDMT) - 4d Molecular Therapeutics Announces FDA Clearance of Ind Application for 4d-710, an A101 Vector-based, Aerosol-delivered Gene Therapy for the Treatment of Cystic Fibrosis Lung Disease.
4d Molecular Therapeutics - Active Ind Enables Initiation of 4d-710 Phase 1/2 Clinical Study Sites, Which is Expected Before Year-end.
4d Molecular-to Focus Initially on About 10-15% of All Patients Whose Disease is Not Amenable to Existing Modulator Medicines That Target Cftr Protein.